Know Cancer

or
forgot password

DPRESS Study. Case-control Study in Cancer Pain: Uncontrolled Pain as Depression Development Predictor in Oncologic Patients


Phase 4
18 Years
N/A
Not Enrolling
Both
Cancer Pain

Thank you

Trial Information

DPRESS Study. Case-control Study in Cancer Pain: Uncontrolled Pain as Depression Development Predictor in Oncologic Patients


This is a retrospective observational and case-control multicenter study. The main objective
of this study is determine the degree of association between cancer pain and depression by
impact assessment of adequate control of pain associated with cancer risk depression in
patients attending the Oncology Unit. The assessment of pain intensity will be performed by
using visual analogue scales (EVAs) and verbal descriptive scales, as an observational
study, not limit or modify the use of any drug. The patients included in this study have a
medical history of cancer pain and mild depression (Beck = 8). The controls are patients
with history of cancer pain and mild or absent depression (Beck = 7). n/a


Inclusion Criteria:



- Patients =18 years old

- have medical data of = 3 months

- experience pain after cancer diagnosis and complete the Beck Depression Inventory
(BDI)

- patients who give informed written consent

- patients with no mental or physical disorders that unable them to complete the BDI.

Exclusion Criteria:

- Patients with diagnosis of depression before cancer diagnosis

- patients with chronic pain prior to the diagnosis of cancer, and cancer disease has
not changed its course

- patients with other previous mental disorders

- patients who do not give their informed written consent.

Type of Study:

Observational

Study Design:

Observational Model: Case Control, Time Perspective: Retrospective

Outcome Measure:

Beck Depression Inventory

Outcome Time Frame:

3 months

Safety Issue:

No

Principal Investigator

Janssen-Cilag S.A. (formerly Janssen Sp) Clinical Trial

Investigator Role:

Study Director

Investigator Affiliation:

Janssen-Cilag, S.A.

Authority:

Spain: Spanish Drug Agency

Study ID:

CR017656

NCT ID:

NCT01402830

Start Date:

November 2007

Completion Date:

March 2008

Related Keywords:

  • Cancer Pain
  • cancer
  • depression
  • pain
  • Depression
  • Depressive Disorder

Name

Location